Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients

• Sponsor: Gachon University Gil Medical Center (Other)
• Overall Status: Completed
• CT.gov ID: NCT00745407
• Collaborator: (none)
• Location: 1
• Arm: 1
• Duration (Months): 43

Study Details

Study Description

Brief Summary

Fenofibrate increases adiponectin levels, but reduces leptin levels

Condition or Disease	Intervention/Treatment	Phase
Hypertriglyceridemia	Drug: fenofibrate	Phase 4

Study Design

• Study Type: Interventional
• Intervention Model: Crossover Assignment
• Primary Purpose: Treatment
• Study Start Date: Jan 1, 2005
• Actual Study Completion Date: Aug 1, 2008

Arms and Interventions

Arm	Intervention/Treatment
Experimental: fenofibrate 160 mg, placebo	Drug: fenofibrate

Outcome Measures

Primary Outcome Measures

Eligibility Criteria

Criteria

• Ages Eligible for Study: 25 Years to 80 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• hypertriglyceridemia

Exclusion Criteria:

• chronic liver disease

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Gil Medical Center	Incheon		Korea, Republic of	405760

Sponsors and Collaborators

• Gachon University Gil Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• ClinicalTrials.gov Identifier: NCT00745407
• Other Study ID Numbers: GMC 200511
• First Posted: Sep 3, 2008
• Last Update Posted: Sep 3, 2008
• Last Verified: Sep 1, 2008

• Keywords provided by , ,: adipocytokines; insulin sensitivity; hypertriglyceridemic patients
• Additional relevant MeSH terms: Hypertriglyceridemia; Fenofibrate

Study Results

No Results Posted as of Sep 3, 2008